FDA Approved: LIORESAL (BACLOFEN) — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a supplemental application for LIORESAL (baclofen) from Amneal Pharmaceuticals LLC, updating the product labeling as requested in the submission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spasticity Due to Multiple Sclerosis
• Spasticity Due to Spinal Cord Injury

Drugs mentioned

• LIORESAL (BACLOFEN)

Snippet

SUPPL AP for LIORESAL (BACLOFEN) (BACLOFEN)